Tuberculosis trials in South Korea
6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis
- Where
- Busan, Incheon, Seoul
- Age
- 14 years and over
- People
- 532 worldwide
- Run by
- Otsuka Pharmaceutical Development & Commercialization, Inc.
See details and how to joinNCT07209761 - Phase 1Taking peopleID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74
- Where
- Gwangmyeong, Seoul, Suwon
- Age
- 55 years to 74 years
- People
- 144
- Run by
- Quratis Inc.
See details and how to joinNCT06714513 - No phaseTaking peopleLIFE-TB ; Long-Term Impacts on Lung Health and Life After Tuberculosis in Korea
- Where
- Seoul
- Age
- 19 years and over
- People
- 360
- Run by
- Yonsei University
See details and how to joinNCT06946784 - Phase 4Taking peopleBPaL(M) Regimen for the Treatment of MDR/RR-TB
- Where
- Seoul
- Age
- 19 years and over
- People
- 80
- Run by
- Asan Medical Center
See details and how to joinNCT05381194 - Phase 3Not yet taking people in South KoreaTreatment Shortening of Drug-Sensitive Pulmonary Tuberculosis Using High Dose Rifampicin (Hi-DoRi-3)
- Where
- Seoul
- Age
- 19 years to 85 years
- People
- 926
- Run by
- Seoul National University Hospital
See details and how to joinNCT04485156 - No phaseTaking peopleSeoul National University Airway Registry
- Where
- Seongnam-si, Seoul
- Age
- 20 years to 90 years
- People
- 800
- Run by
- Seoul National University Hospital
See details and how to joinNCT02527486